Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
February 11, 202637m 17s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr Marwan Fakih, including the following topics:
- Overview of etiology, incidence and staging of squamous cell cancer of the anal canal (SCAC) (0:00)
- Systemic therapy approaches to the management of recurrent unresectable and metastatic SCAC (6:17)
- Available data with anti-PD-1 (pembrolizumab, nivolumab, retifanlimab) and anti-CTLA-4 (ipilimumab) agents in the management of unresectable metastatic SCAC previously treated with chemotherapy (12:59)
- Immunotherapy combined with chemotherapy for the front-line treatment of SCAC (20:48)
- Efficacy and safety of retifanlimab combined with carboplatin/paclitaxel as first-line treatment for SCAC in the Phase III POD1UM-303 trial (23:43)